JOURNAL ARTICLE
Supreme Court for Now Restores Abortion Pill Access by Mail.
Published In: Bloomberg.com, 2026. P. N.PAG 1 of 3
Database: Business Source Ultimate 2 of 3
Authored By: Stohr, Greg 3 of 3
Abstract
The article focuses on the US Supreme Court’s temporary restoration of access to mifepristone, a widely used abortion pill, by mail, pausing a recent ruling that required in-person healthcare visits. Justice Samuel Alito issued an administrative stay extending access until May 11, allowing the court more time to address a 5th US Circuit Court of Appeals decision that restricted mailing the drug, which was challenged by manufacturers Danco Laboratories LLC and GenBioPro Inc. The 5th Circuit ruling favored Louisiana’s lawsuit against the FDA’s expanded mail-order access to mifepristone, citing state abortion bans and medical costs from complications. The FDA had previously eased restrictions on mifepristone during the Biden administration, while reproductive rights groups maintain the drug’s safety. [Extracted from the article]
Additional Information
- Source:Bloomberg.com. 2026/05, pN.PAG
- Document Type:Article
- Subject Area:Law
- Publication Date:2026
- Accession Number:193500770
- Copyright Statement:Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.